ERBB2 and breast cancer: LECs were enriched by depleting CD45+ cells from single-cell suspensions and subsequently sorting podoplanin (PDPN)+ CD31+ LECs from distant and metastatic LNs of seven patients with luminal and two with Her2-positive breast cancer (Fig. 1a, b and Supplementary Fig. 1a).